Nissui

Nissui Corporation is a global leader in marine products that has successfully diversified into the pharmaceutical and fine chemicals sectors. The company is a pioneer in the research and commercialization of omega-3 fatty acids, specifically high-purity Eicosapentaenoic acid (EPA). Its flagship pharmaceutical product, Epadel, is widely used in Japan for treating hyperlipidemia and arteriosclerosis. Beyond finished pharmaceuticals, Nissui is a major supplier of pharmaceutical-grade EPA and DHA ingredients to global markets. The company continues to leverage its marine resource expertise to develop functional foods and specialized medical nutrition. Its advanced purification technologies allow for the production of ultra-high purity lipids that meet stringent global pharmacopeia standards.